CELL & gene THERAPY steering committee

Mission

To build and advance the supply chain of this nascent medical science by

  • promoting collaboration among the emerging stakeholders;
  • creating a platform for exchange of business knowledge and experience;
  • fostering commercialization and scaling up of CAR-T Cell Therapy;
  • incorporating agility, accountability, quality and integrity in the business end-to-end;
  • and enabling the delivery of affordable healthcare in the long run.

The Supply Chain challenges are truly Draconian with the production batch size of one, where the environment of temperature control, chain of custody, overall product and process  integrity, and reliability of supply of manufacturing materials is demanding. It is an unprecedented challenge for science and business to come together.

    Chairperson

    Devendra Mishra

    Devendra Mishra

    Executive Director, BSMA

    Members
    Heather Erickson

    Heather Erickson

    Vice President, Global Supply Chain, Sangamo

    Dr. Alison Moore

    Dr. Alison Moore

    CTO, Allogene Therapeutics

    Bernard Huyghe

    Bernard Huyghe

    Director, External Supply, Allogene Therapeutics

    Matthew Yedwabnick, Sr.

    Matthew Yedwabnick, Sr.

    Director Supply Chain, Atara Biotherapeutics

    Franck Toussaint

    Franck Toussaint

    Managing Director, Biolog Europe

    Kenneth Locke

    Kenneth Locke

    Vice President, Manufacturing, Carisma Therapeutics

    Kimberly Foster

    Kimberly Foster

    Scientific Director, Bristol Myers Squibb

    David Karakas

    David Karakas

    Director, Procurement & Sourcing, Bluebird Bio

    Jayant Aphale

    Jayant Aphale

    Former Executive Vice President of Technical Operations, Gritstone Oncology

    Neil Ackerman

    Neil Ackerman

    Senior Director, Enterprise Supply Chain Global Planning and Innovation, Johnson and Johnson

    Deidre Hobbs

    Deidre Hobbs

    Senior Director, Quality, Kite Pharma

    Howard Bland, Sr.

    Howard Bland, Sr.

    Director, Sourcing & Procurement, Kite Pharma

    Sophia-Donaldson

    Sophia-Donaldson

    Head Global Strategic Sourcing, Kite Pharma

    Reggie Foster

    Reggie Foster

    Director Logistics and Packaging Engineering, Kite Pharma

    Kirstin Powell

    Kirstin Powell

    Vice President Quality Assurance, Talaris

    Peter Holman

    Peter Holman

    Global Apheresis Integration, Novartis

    Ran Zheng

    Ran Zheng

    Former CTO, Orchard Therapeutics

    Heather Steinmetz

    Heather Steinmetz

    QA Manager for Bone Marrow Transplant, UCLA

    Robert Bottome

    Robert Bottome

    Vice President, Global Supply Chain, BioMarin

    Aileen Baquiran

    Aileen Baquiran

    Vice President, Global Supply Chain, Orchard Therapeutics

    Jon Miller

    Jon Miller

    Director, Head of Supply Chain, PACT Pharma

     Mandar Paralkar, Sr.

    Mandar Paralkar, Sr.

    Director and Digital Innovation Advisor of Life Sciences, SAP

    Jon Pieter Kapelle

    Jon Pieter Kapelle

    Vice President of Strategy, 4G Clinical

     Kevin Cast

    Kevin Cast

    Partner, Archbow Consulting (Omnicom Health Group)

    Paul Furgal

    Paul Furgal

    Vice President, Archbow Consulting (Omnicom Health Group)

    Greg Bodnar, Sr.

    Greg Bodnar, Sr.

    Manager, Client Engagement, BeTheMatch

     Bob Lamont

    Bob Lamont

    Director and Digital Innovation Advisor of Life Sciences, SAP

    Guy Carlo

    Guy Carlo

    Vice President and GM, ThermoFisher Scientific

    Carla Reed

    Carla Reed

    CEO, New Creed

    Documents

    2019 Conference Documents

    Notes from 0814 Meeting

    OPERATIONS–THE GATEWAY TO SUCCESS IN CELL AND GENE THERAPIES

    Navigating the Unique Manufacturing Challenges in Cell and Gene Therapy

    Commercial Considerations for Planning a Successful Cell and Gene Therapy Product Launch

    Overcoming Complexities of the Personalized Medicine Supply Chain

    2018 Conference Documents

    END TO END CONSIDERATIONS FOR IMMUNOTHERAPY PRODUCTS

    Global Sourcing of Materials & Technologies for CAR T Therapy Commercialization

    Sourcing, Vetting, Contracting and Developing Reliable Supply

    Proactive Establishment of Compliance Measures Ahead of FDA Regulations

    Pin It on Pinterest

    Share This